NCT07404488

Brief Summary

Rapid maxillary expansion (RME) is used to correct transverse deficiencies of the maxilla. This randomized controlled trial compares three RME devices in adolescents (age 10-15) with at least 8 mm maxillary transverse deficiency: (1) bone-borne expander supported by two palatal miniscrews, (2) bone-borne expander supported by four palatal miniscrews, and (3) conventional tooth-borne Hyrax expander. Devices were placed using static computer-guided miniscrew insertion (where applicable). All participants received the same activation protocol to reach 8 mm expansion. Cone-beam CT scans were obtained pre-treatment (T0) and at 6 months post-treatment (T1). The trial assesses skeletal, dentoalveolar, periodontal, and nasal/airway outcomes. Enrollment: 36 subjects. Study sites: Sapienza University of Rome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 4, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 11, 2026

Completed
Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

2.8 years

First QC Date

February 4, 2026

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in maxillary basal width (MaxBas) from baseline (T0) to 6 months post-treatment (T1)

    Measurement method: CBCT (Simplant software) distance between alveolar/basal points (points 5-6 as per Podesser/Garib protocol).

    at 6 months

Study Arms (3)

Arm 1 (Group A) - Two-miniscrew bone-borne expander

EXPERIMENTAL

one-borne rapid maxillary expander anchored on two palatal miniscrews inserted in paramedian palatal vault (near first-second premolar area). Miniscrews: self-tapping titanium (Benefit system; PSM Medical Solutions). Placement planned via CBCT-guided CAD/CAM surgical guide (Easy Driver). Activation protocol: Hyrax click 10 mm screw: 4 quarter-turns at placement then 3 quarter-turns/day for 12 days (0.20 mm/turn) until \~8 mm expansion.

Device: Miniscrew supported expander application

Arm 2 (Group B) - Four-miniscrew bone-borne expander

EXPERIMENTAL

Bone-borne rapid maxillary expander anchored on four palatal miniscrews (two paramedian + two parapalatine). Same guided insertion workflow and activation protocol as Group A.

Device: 4 miniscrews supported rapid maxillary expansion application

Arm 3 (Group C) - Conventional tooth-borne Hyrax expander

ACTIVE COMPARATOR

Tooth-borne Hyrax expander banded on upper first permanent molars (conventional Hyrax). Same activation protocol as Groups A/B.

Device: Conventional tooth-borne Hyrax expander (comparator)

Interventions

Hyrax-type tooth-borne expander with bands cemented on upper first molars (Hyrax click 10 mm).

Arm 3 (Group C) - Conventional tooth-borne Hyrax expander

Two palatal miniscrews with custom bone-borne expansion framework (device transmits forces to palatal bone; no tooth bands).

Arm 1 (Group A) - Two-miniscrew bone-borne expander

Four palatal miniscrews with custom bone-borne expansion appliances.

Arm 2 (Group B) - Four-miniscrew bone-borne expander

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 10 to 15 years (under 16 at enrollment).
  • Late mixed or permanent dentition.
  • Maxillary transverse deficiency ≥ 8 mm (unilateral or bilateral).
  • Parent/guardian able to provide written informed consent; participant assent where applicable.

You may not qualify if:

  • Poor oral hygiene.
  • Prior orthodontic treatment.
  • Craniofacial syndromes.
  • Cleft lip and/or palate.
  • Genetic or congenital diseases likely to affect craniofacial growth or bone quality.
  • Inability/unwillingness to attend scheduled follow-up visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sapienza University of Rome

Rome, Rm, 00161, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, DDS, PhD

Study Record Dates

First Submitted

February 4, 2026

First Posted

February 11, 2026

Study Start

November 1, 2021

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations